Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

View source ↗

Summary

Prospective clinical investigation evaluating the Vanguard 360 Revision Knee for knee arthroplasty revision; sponsor is Zimmer Biomet, and the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Rheumatoid Arthritis | Status: ACTIVE_NOT_RECRUITING